Hims & Hers Health reports first quarter revenue below expectations, with a loss of $0.4 per share

Golden Finance May 12 | Hims & Hers Health announced that its first quarter sales amounted to $608 million, a year-on-year increase of 3.8%, falling short of analysts' average expectation of $617 million. During this period, the company unexpectedly recorded a loss of $0.4 per share, while analysts had expected a profit of $0.04 per share; in the same period last year, the company achieved a profit of $0.2 per share. The Chief Financial Officer of Hims & Hers expects the company to return to profitability in 2027.